Nihar Desai: How GvHD Prophylaxis Influences The Risk of Second Primary Malignancies After Allogeneic Transplants
Nihar Desai, Allogeneic Bone Marrow Transplant Fellow at Princess Margaret Cancer Centre, posted on X about recent paper he and colleagues co-authored, published in British Journal of Haematology.
“Now out in British Journal of Haematology.
Our latest work from the Princess Margaret Cancer Center explores how GvHD prophylaxis influences the risk of second primary malignancies after allogeneic transplants using a large cohort of 1,418 patients (>6000 person-years of follow up).”
Title: Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation
Authors: Nihar Desai, Eshrak Al-Shaibani, Tommy Alfaro-Moya, Arjun D. Law, Wilson Lam, Mats Remberger, Ivan Pasic, Igor Novitzky-Basso, Auro Viswabandya, Dennis D. Kim, Rajat Kumar, Jeffrey H. Lipton, Jonas Mattsson, Fotios V. Michelis
Read The Full Article at British Journal of Haematology.
More posts featuring Nihar Desai.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023